Skip to main content

Together we are beating cancer

Donate now

Tim Gunn

Tim is a senior digital news officer at Cancer Research UK. He started writing about science after studying English literature at Cambridge and magazine journalism at City, University of London. Before joining the digital news team in August 2022, he was a journalist and medical magazine editor.
Tim Gunn
Showing 12 out of 38 results
Cancer cells with extrachromosomal DNA (ecDNA)

Cancer Grand Challenges team eDyNAmiC has changed our understanding of how oesophageal cancer starts. In some cases, mutations scientists thought were a late effect of the disease could actually be driving it in the first place. The findings could give us a new way to intercept cancer before it becomes dangerous. Cancer Grand Challenges team eDyNAmiC has changed our understanding of how oesophageal cancer starts. In some cases, mutations scientists thought were a late effect of the disease could actually be driving it in the first place. The findings could give us a new way to intercept cancer before it becomes dangerous.

by Tim Gunn | In depth | 23 October 2023

23 October 2023

Steph Phillips, Dr Miriam Dixon-Zegeye & Professor Sarah Blagden

We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease. We're funding the UK's first precision cancer prevention trial unit. It's testing a drug that could help protect people with Li Fraumeni Syndrome, a genetic condition that can lead to a more than 90% lifetime risk of cancer, against the disease.

by Tim Gunn | In depth | 19 September 2023

19 September 2023

Two cancer researchers looking at a cell image on screen

The UK is rejoining Horizon Europe, the EU’s £81bn flagship funding scheme for scientific research. The agreement will bring more funding for cancer researchers in the UK, as well as more opportunities for collaboration across Europe. The UK is rejoining Horizon Europe, the EU’s £81bn flagship funding scheme for scientific research. The agreement will bring more funding for cancer researchers in the UK, as well as more opportunities for collaboration across Europe.

by Tim Gunn | News | 7 September 2023

7 September 2023

Graphic announcing the Cancer Grand Challenges shortlist

The Cancer Grand Challenges shortlist includes 12 teams with the potential to make the progress against cancer that we urgently need. The Cancer Grand Challenges shortlist includes 12 teams with the potential to make the progress against cancer that we urgently need.

by Tim Gunn | News | 5 September 2023

5 September 2023

An African elephant walking along a dirt track

For World Elephant Day, we're taking a look at why elephants so rarely get cancer. Could the ways they protect themselves help people too? For World Elephant Day, we're taking a look at why elephants so rarely get cancer. Could the ways they protect themselves help people too?

by Tim Gunn | Analysis | 12 August 2023

12 August 2023

Aneurin Bevan, founder of the NHS, visits a patient on the service's first day.

To celebrate 75 years of the NHS, we’ve put together a timeline showing some of its biggest contributions to cancer care.   To celebrate 75 years of the NHS, we’ve put together a timeline showing some of its biggest contributions to cancer care.  

by Tim Gunn | In depth | 5 July 2023

5 July 2023

A transgender woman in a hospital gown speaking to her doctor, a transgender man, in an exam room.

Charities, research institutes and health providers across the UK are working to improve LGBTQIA+ cancer care. Here's how. Charities, research institutes and health providers across the UK are working to improve LGBTQIA+ cancer care. Here's how.

by Tim Gunn | Analysis | 23 June 2023

23 June 2023

Lung cancer cells seen through a microscope.
  • Science & Technology
  • Health & Medicine

ASCO 2023 roundup: Blood tests, drugs and exercise

ASCO’s annual meeting is the world’s biggest cancer conference. This year’s highlights included updates on cancer blood tests, AI tools for estimating cancer risk, better drugs for some lung and ovarian cancers, and interesting data on how yoga can help patients. ASCO’s annual meeting is the world’s biggest cancer conference. This year’s highlights included updates on cancer blood tests, AI tools for estimating cancer risk, better drugs for some lung and ovarian cancers, and interesting data on how yoga can help patients.

12 June 2023

Senedd Cymru, or the Welsh Parliament.

Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change. Health inequalities in Wales put deprived communities more at risk of cancer. The All Things Being Equal inquiry shows what has to change.

by Tim Gunn | News | 8 June 2023

8 June 2023

Andrea receiving chemotherapy.

Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that. Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that.

by Tim Gunn | In depth | 22 May 2023

22 May 2023

A magnified image of squamous cell carcinoma, the most common type of cervical cancer

The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland. The immunotherapy pembrolizumab may help some people with incurable cervical cancer live longer. It's now an approved treatment for them in England and Scotland.

by Tim Gunn | News | 16 May 2023

16 May 2023